A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice

Infect Immun. 1994 Dec;62(12):5353-60. doi: 10.1128/iai.62.12.5353-5360.1994.

Abstract

To identify major immunogenic constituents of Candida albicans, the effect of a mannoprotein fraction (MP-F2) on the elicitation of a delayed-type hypersensitivity (DTH) reaction, cytokine production, and protection from a virulent Candida challenge in a mouse candidiasis model was studied. In mice immunized with whole cells of a low-virulence strain of C. albicans and thus protected against a challenge with a highly virulent strain of this fungus, MP-F2 was able to elicit a strong DTH response that was accompanied by splenocyte proliferation in vitro in the presence of Candida antigen. The supernatants of MP-F2-stimulated splenocyte cultures contained gamma interferon (IFN-gamma, a typical CD4+ T helper-1 (Th1) cytokine, but no interleukin-4, (IL-4), a typical CD4+ Th2 cytokine. IFN-gamma was produced by CD4+ cells, and its level could be greatly increased by the addition of anti-IL-4 or, mostly, anti-IL-10 antibodies to the CD4+ cell cultures. Upon a suitable schedule of immunization, MP-F2 was also able to induce a vigorous DTH response in Candida-uninfected mice, a response that could be efficiently transferred into naive recipients by CD4+ cells from the spleens of MP-F2-immunized mice. The immunization described above also conferred to mice a low degree of protection against a virulent Candida challenge, both in terms of median survival time and in the number of Candida cells in the kidney. However, while DTH induction by MP-F2 was as strong as that induced by whole cells, MP-F2-induced protection was significantly weaker than that conferred by Candida whole-cell immunization. Mice immunized with either MP-F2 or Candida whole cells had an inverted ratio between the number of CD4+ splenocytes producing IFN-gamma and that of cells producing IL-4, compared with nonimmunized animals. However, the number of IL-4-producing CD4+ cells was significantly higher in MP-F2-vaccinated, weakly protected mice than in Candida whole-cell-vaccinated, highly protected animals. Overall, our data suggest that the MP-F2 fraction contains one or more major immunogens of C. albicans which are capable of interfering with the balance of CD4+ Th1 and Th2 responses that is so critical in the outcome of host-Candida relationship and are thus potentially relevant in the mechanisms of Candida-specific DTH regulation and protection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Fungal / therapeutic use*
  • CD4-Positive T-Lymphocytes / metabolism
  • Candidiasis / immunology
  • Candidiasis / prevention & control*
  • Cells, Cultured
  • Chimera
  • Cytokines / biosynthesis
  • Fungal Proteins / therapeutic use*
  • H-2 Antigens / genetics
  • Hypersensitivity, Delayed / immunology*
  • Immunotherapy, Active
  • Immunotherapy, Adoptive
  • Interferon-gamma / biosynthesis
  • Interleukin-10 / biosynthesis
  • Interleukin-4 / biosynthesis
  • Kidney / microbiology
  • Membrane Glycoproteins / immunology*
  • Mice
  • Mice, Inbred Strains
  • Spleen / cytology
  • Spleen / metabolism
  • Survival Analysis
  • T-Lymphocytes, Helper-Inducer / immunology

Substances

  • Antigens, Fungal
  • Cytokines
  • Fungal Proteins
  • H-2 Antigens
  • Membrane Glycoproteins
  • mannoproteins
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma